Table 3 Treatment outcomes of ASAQ, AL and DHAPQ at day 35 and day 42
Outcomes | Uncorrected | PCR-corrected | ||||||
|---|---|---|---|---|---|---|---|---|
DHAPQ (N = 148) | AL (N = 162) | ASAQ (N = 160) | p value | DHAPQ (N = 148) | AL (N = 162) | ASAQ (N = 160) | p value | |
% (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |||
Day 35 | ||||||||
Late parasitological failure | 1/148 | 1/162 | 2/160 | 00 | 00 | 1/160 (0.625%) | ||
(0.67%) | (0.62%) | (1.25%) | ||||||
ACPR | 147/148 | 161/162 | 158/160 | 0.79 | 148/148 | 162/162 | 159/160 | 0.37 |
(99.33%) | (99.38%) | (98.75%) | (100%) | (100%) | (99.375%) | |||
[85.1-99.9] | [85.7-99.9] | [86.2-99.9] | [84.5-99.9] | [85.2-99.9] | [85.6-99.9] | |||
Day 42 | DHAPQ (N = 134) | AL (N = 141) | ASAQ (N = 136) | DHAPQ (N = 134) | AL (N = 141) | ASAQ (N = 136) | ||
% (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |||
Late parasitological failure | 1/134 | 4/141 | 4/136 | 00 | 00 | 1/136 | ||
(0.75%) | (2.84%) | (3%) | (0.73%) | |||||
ACPR | 133/134 | 137/141 | 132/136 | 0.38 | 134/134 | 141/141 | 135/136 | 0.36 |
(99.25%) | (97.16%) | (97%) | (100%) | (100%) | (99.27) | |||
[84.4-99.9] | [86.6-99.9] | [87.1-99.9] | [83.7-99.9] | [84.2-99.9] | [84.5-99.9] | |||